Ho Index for Ulcerative Colitis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Intermediate Risk2–3
- High Risk4–9
The Ho Index for Ulcerative Colitis calculator is designed for bedside predicting outcome of medical therapy in severe ulcerative colitis by assessing risk of failure of corticosteroid therapy on day 3 of admission in clinical practice. The resulting score directly guides clinician decision-making regarding timing.
Clinical Guidelines & Evidence
Predicts outcome of medical therapy in severe ulcerative colitis by assessing risk of failure of corticosteroid therapy on day 3 of admission.
Clinical Indication
The Ho Index for Ulcerative Colitis is indicated for bedside clinical practice to support Predicts outcome of medical therapy in severe ulcerative colitis by assessing risk of failure of corticosteroid therapy on day 3 of admission.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Score has 85% sensitivity and 75% specificity at cutoff ≥4 for predicting non-response.
Ho Index Score = Stool Frequency Points + Colonic Dilatation Points + Hypoalbuminemia Points
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| mean_stool_frequency | string | Yes | Mean stool frequency in stools per 24 hours on day 3 of admission |
| colonic_dilatation | string | Yes | Presence of colonic dilatation (≥5.5cm on abdominal X-ray) within first 3 days |
| hypoalbuminemia | string | Yes | Presence of hypoalbuminemia (albumin ≤3 g/dL or ≤30 g/L) on day 3 |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | Score 0-1 |
| 2–3 | Intermediate Risk | Score 2-3 |
| 4–9 | High Risk | Score ≥4 |
Evidence-Based References (EBM)
- Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004 May 15;19(10):1079-87.
- Lynch RW, Churchhouse AM, Protheroe A, Arnott ID; UK IBD Audit Steering Group. Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data. Aliment Pharmacol Ther. 2016 Jun;43(11):1132-41.